 Name: ___        Unit No:  ___  Admission Date: ___       Discharge Date:  ___  Date of Birth: ___       Sex:  F  Service: MEDICINE  Allergies: Ampicillin / Penicillins / Percocet / Bactrim / Gold Salts  Attending: ___.  Chief Complaint: Nose bleed  Major Surgical or Invasive Procedure: Blood transfusion 

 History of Present Illness: HPI: ___ hx of RA, OA, pulmonary artery hypertension, chronic pulmonary embolism on lovenox and a new diagnosis of myelofibrosis presented to the ED with epistaxis and is admitted for monitoring. 

She was recently admitted ___ to ___ for anemia thought secondary to new diagnosis of myelofibrosis vs myelofibrosis with myelodysplasia, vs spent phase polycythemia ___ on bone marrow biopsy. She was also started on Lovenox for chronic Pulmonary emboli and doxycycline for left lower extremity cellulitis.

This morning she had about 45 minute oozing nose-bleed after she picked her nose. HCT was checked and found to be 24.1 there was no report of respiratory distress or hemodynamic instability, she was referred to the ED for a transfusion. 

On arrival to the ED, vitals were Vital Signs: Pulse: 78, RR: 18, BP: 150/71, O2Sat: 99, O2Flow: 4L. Epistaxis had resolved and whs was without complaints. Exam showed continued erythemia at the right lower extremity at the site of cellulitis. Labs showed Hgb 8.5/HCT 26.4 (previously HGB 9.1/HCT 28.4) WBC 10.5 Platelet 1380 (1173 prviously) INR 1.5. She was given vancomycin 1g IV admitted for a transfusion and apparent RLE cellulitis that has not responded to PO antibiotics. Vitals on transfer 78, 150/71, 18, 99% 4L NC

On arrival to the floor, vitals T: 98.3 BP: 150/84 P:80 RR 16 SaO2 98% 2LNC she reports epistaxis has not returned, and states that her left lower extremity is overall improved since discharge previously. She complains of itching at her lower back. 

Review of systems:  (+) Per HPI  (-) Denies fever, chills, night sweats. Denies headache, sinus  tenderness, rhinorrhea or congestion. Denied cough,chest pain or  tightness, palpitations. Denied vomiting, diarrhea, constipation  or abdominal pain. No recent change in bowel or bladder habits. 

No dysuria.   Past Medical History: 1. Seropositive nonerosive rheumatoid arthritis 2. SIADH of unclear etiology (___) 3. Chronic venous insufficiency 4. Osteopenia w/ L2-L3 compression fracture 5. HTN 6. Deafness 7. Depression 8. Arthritis 9. Obesity 10. Urinary Incontinence 11. HL 12. wet macular degeneration 13. BCC on nasal bridge s/p excision in ___  Social History: ___ Family History: Noncontributory  Physical Exam: Admission Vitals: T: 98.3 BP: 150/84 P:80 RR 16 SaO2 98% 2LNC General: Elderly female very hard of hearing Pleasant and in NAD 

HEENT: Crusted blood at anterior nares bilaterally, No blood in the oral pharynx Neck: supple, no LAD  Lungs: CTAB no wheezes/rales/ronchi CV: RRR, normal S1 + S2, no murmurs, rubs, gallops  Abdomen: soft, non-tender, non-distended, no rebound tenderness or guarding  Ext: Left lower extremity shows dry scaling skin with an area of ill defined erythema extending beyone the markings made in the ED, warmer than the right lower extremity with non pitting edema. RLE without erythemia. 2+ pulses.

Discharge:  Vitals: T: 98.3 BP: 150/84 P:80 RR 16 SaO2 98% 2LNC General: Elderly female very hard of hearing Pleasant and in NAD 

HEENT: Crusted blood at anterior nares bilaterally, No blood in the oral pharynx Neck: supple, no LAD  Lungs: CTAB no wheezes/rales/ronchi CV: RRR, normal S1 + S2, no murmurs, rubs, gallops  Abdomen: soft, non-tender, non-distended, no rebound tenderness or guarding  Ext: Left lower extremity shows dry scaling skin with an area of ill defined erythema extending beyone the markings made in the ED, warmer than the right lower extremity with non pitting edema. RLE without erythema. Bruise on right medial leg. Marked stable nontender to palpation. 2+ pulses.

Discharge: 

 Pertinent Results: ___ 06:15AM BLOOD WBC-8.9 RBC-3.11* Hgb-9.2* Hct-28.6* MCV-92 MCH-29.6 MCHC-32.2 RDW-16.9* Plt ___ ___ 06:35AM BLOOD WBC-8.4 RBC-2.53* Hgb-7.7* Hct-24.2* MCV-96 MCH-30.3 MCHC-31.8 RDW-17.4* Plt ___ ___ 05:50PM BLOOD Neuts-62 Bands-2 ___ Monos-3 Eos-7* Baso-0 ___ Myelos-0 ___ 06:35AM BLOOD Glucose-80 UreaN-17 Creat-0.7 Na-134 K-5.0 Cl-99 HCO3-27 AnGap-13

Imaging: None

Micro: None

Pending: Blood cultures.  Brief Hospital Course: ___ with multiple DVT's, PE's currently on lovenox, recently diagnosed with myelodysplastic syndrome who presents in the setting of a resolved mild nose bleed and anemia for which she was transfused two units. 

#MDS ___ has recently been diagnosed with MDS. ___ has a very high platelet count with concomitant severe macrocytic anemia. She is now blood transfusion dependent. This was diagnosed upon her last hospital visit. While she was at her ___ facility, the ___ reports "picking her nose" which resulted in a slow nose bleed which lasted approximately 45 minutes. Per the ___, the bleed was very slow and not large in volume. By the time she had arrived at the emergency department, her bleed had stopped. However, her hematocrit was 24. She was transfused two units of RBCs with an appropriate increase in HCT. 

#Anticoagulation: Secondary to the ___ blood dyscrasia which puts her at risk for clots, she was continued on lovenox and aspirin per recommendations of heme-onc. On her follow up appointment with heme/onc, discussion regarding possible transition to warfarin will be discussed.

#Hypoxemia: This was stable during this admission and the ___ remained on her home oxygen which was started on previous admission. She is ___ on 1L NC at rest. 

#Cellulitis: The ___ has a mild case of left lower extremity cellulitis which is being treated with a total 10 day course of doxycycline. Of note, the area has not increased in size, redness, or warmth. It is slowly resolving. 

Code Status: After discussion with her PCP, ___, the ___ was made DNR/DNI. 

Transitional issues: 1. Anticoagulation: Until a new plan is established with her hematologists the ___ will remain on lovenox 80mg sq BID and aspirin 81mg qd for VTE ppx. 2. Your facility will be contacted by hematology in order for the ___ to establish follow up with heme-onc at ___ to arrange for the ___ to receive blood transfusions in the outpatient setting if clinically indicated. 3. CBC draws QoD and fax results to Office ___, MD ___

 Medications on Admission: 1. enoxaparin 80 mg/0.8 mL Syringe Sig: Eighty (80) mg Subcutaneous Q12H (every 12 hours). 2. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily). 3. valsartan 160 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). 4. doxycycline hyclate 100 mg Capsule Sig: One (1) Capsule PO Q12H (every 12 hours) for 4 days. 5. simvastatin 10 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). 6. citalopram 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 7. folic acid 1 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). 8. Xanax 0.25 mg Tablet Sig: One (1) Tablet PO at bedtime. 9. dorzolamide-timolol ___ % Drops Sig: One (1) Drop Ophthalmic BID (2 times a day). 10. acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO TID (3 times a day) as needed for pain. 11. calcitonin (salmon) 200 unit/actuation Spray, Non-Aerosol Sig: One (1) spray Nasal DAILY (Daily). 12. brimonidine 0.15 % Drops Sig: One (1) Drop Ophthalmic BID (2 times a day). 13. triamcinolone acetonide 0.1 % Ointment Sig: One (1) Appl Topical TID (3 times a day) as needed for itching. 14. Calcium 500 + D 500 mg(1,250mg) -400 unit Tablet Sig: ___ Tablets PO twice a day.  Discharge Medications: 1. enoxaparin 80 mg/0.8 mL Syringe Sig: Eighty (80) mg Subcutaneous Q12H (every 12 hours).  2. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily).  3. valsartan 160 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).  4. doxycycline hyclate 100 mg Capsule Sig: One (1) Capsule PO Q12H (every 12 hours) for 4 days.  5. simvastatin 10 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).  6. citalopram 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  7. folic acid 1 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). 

8. Xanax 0.25 mg Tablet Sig: One (1) Tablet PO at bedtime.  9. dorzolamide-timolol ___ % Drops Sig: One (1) Drop Ophthalmic BID (2 times a day).  10. acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO TID (3 times a day) as needed for pain.  11. calcitonin (salmon) 200 unit/actuation Spray, Non-Aerosol Sig: One (1) spray Nasal DAILY (Daily).  12. brimonidine 0.15 % Drops Sig: One (1) Drop Ophthalmic BID (2 times a day).  13. triamcinolone acetonide 0.1 % Ointment Sig: One (1) Appl Topical TID (3 times a day) as needed for itching.  14. Calcium 500 + D 500 mg(1,250mg) -400 unit Tablet Sig: ___ Tablets PO twice a day.  15. Outpatient Lab Work CBC every 48 hours. Please call results into the office of ___ ___, MD ___ 

 Discharge Disposition: Extended Care  Facility: ___  Discharge Diagnosis: 1. Myelodysplastic Syndrome

 Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair.

 Discharge Instructions: Dear Ms. ___, 

You were admitted to the hospital with anemia which means you have a low level of blood. You also have too many platelets which has been causing you blood clots. This is because you have an abnormality in your bone marrow (the area where blood is made). Since your bone marrow does not properly make blood, you will require blood transfusions going forward which you will be able to get as an outpatient. However, this will need to arranged through the hematologists at ___. They will be in contact with you. 

You still have some residual left lower leg cellulitis. It is very mild. We will continue to treat you with 5 more days of an antibiotic called doxycycline. 

Continue: Doxycycline 100mg twice a day for 4 days. 

If you experience any of the danger symptoms as listed below please talk to the physicians on staff at your facility and consider coming back to the ___ emergency department.  Followup Instructions: ___ 